StockMonkey v2.0 - TRADING TERMINAL

0.4% uninvested

9/10 positions

S&P 500

MSFT

TSLA

Symbol	Company	Sector	Invested	Return today	Return	Details
LMT	Lockheed	N/A	5.9%	-1.53%	+1.39% 10 days
EQIX	Equinix	Data Centers / Real Estate	11.5%	+1.21%	-2.27% 9 days	The Guardian’s piece on Kevin O’Leary’s Stratos datacenter and the broader “insatiable thirst” of datacenters for power and cooling underscores how AI is driving a structural capacity build-out rather than a one-off spike. As the leading global colocation REIT, Equinix monetizes this via long-term, contracted interconnection and power-hungry workloads, and while rate-hike fears from the strong US jobs print weigh on REITs tactically, the secular demand narrative is intact. Compared with chasing single-name AI hardware winners after big runs (a pattern your learning notes flag as risky), EQIX gives you AI/infra exposure with more diversified tenant risk and historically steadier trend behavior for a 1–2 week trade with a tight stop.
SLB	SLB Limited	Energy Services	11.0%	+0.31%	-0.92% 6 days	Current headlines highlight renewed Iran–Israel strikes, Houthi threats to shipping and partial closure of the Strait of Hormuz, all of which have pushed Brent crude sharply higher and increased concern about supply security. Service majors like Schlumberger tend to benefit from sustained higher prices via increased upstream capex across OPEC, US shale and international operators, rather than relying on any one geography. Historically SLB has broad analyst coverage with a positive bias, diversified revenue by region and product line, and operating leverage to drilling and reservoir services, making it attractive for a 1–2 week tactical trade tied to oil‑market volatility. Compared with smaller or more levered E&Ps, a liquid large‑cap service name also fits better with your process improvements around avoiding thinly traded, headline‑only names and managing downside with a 6% stop.
NVO	Novo Nordisk	Healthcare	8.6%	-0.18%	+4.49% 5 days	A recent CNBC piece noted that a weight‑loss drug developer sank about 25% after new trial data showed meaningful side‑effect concerns and higher dropout rates, spooking investors about its commercial opportunity; that setback indirectly strengthens the competitive position of incumbents like Novo Nordisk whose GLP‑1 portfolio is already on market and well‑validated. At the same time, broader coverage continues to emphasize how obesity and diabetes treatments remain one of the few healthcare areas with strong secular demand and pricing power, even as other sectors face reimbursement and patent‑cliff risk. For a 14‑day trade, the combination of a competitor‑specific negative shock and a still‑intact multi‑year demand story gives NVO scope for relative strength without needing a speculative binary catalyst.
AMZN	Amazon	Consumer / Technology	10.4%	-1.23%	-2.26% 5 days	The Guardian’s business section reported that Amazon’s main UK arm saw pre‑tax profits jump more than 25% to £355m on 11% revenue growth, alongside £5.2bn in infrastructure capex and a net £7.6m tax credit tied to investment incentives—signalling robust demand and ongoing expansion of fulfilment centers, data centers and logistics. Separately, CNBC highlighted Amazon as the counterparty in Corning’s big AI data‑center fiber deal, reinforcing that AWS is one of the primary buyers of AI‑related infrastructure at a time when OpenAI, Anthropic and SpaceX IPO headlines are keeping market attention on who will actually monetize AI workloads. Relative to your past experience buying mega‑cap tech into stretched, post‑event charts, Amazon here has a mix of solid fundamental news flow and indirect AI leverage without being the most speculative part of the stack.
CRWD	CrowdStrike Holdings	Technology	7.4%	-1.24%	+6.29% 5 days	Multiple UK business stories describe a wave of AI‑enabled fraud and misinformation: the Bank of England warned about AI deepfake scams involving impersonations of public figures, Ofcom is forcing social platforms to implement “crisis protocols” to contain illegal viral content, and wider coverage of Section 702 surveillance and intelligence law fights in Washington underlines how cyber and data security remain central policy concerns. While no single article names CrowdStrike, they collectively signal rising urgency around detecting breaches, identity misuse and adversarial AI, areas where CrowdStrike’s Falcon platform and MDR offerings are core enterprise tools. Given your short horizon and the stock’s history of responding positively to security‑headline clusters, a modest position adds an AI‑security angle that is thematic but still tied to concrete regulatory and threat‑environment news rather than pure hype.
PANW	Palo Alto Networks	Technology	9.1%	+0.03%	+7.33% 5 days	The same set of headlines that underscore AI abuse—BoE warnings on deepfake scams, Ofcom’s mandated emergency protocols for social media, and debates over powerful U.S. surveillance tools—also imply more spending on perimeter, cloud and application security to monitor content and stop account takeovers at scale. Palo Alto’s broad platform across next‑gen firewalls, SASE and cloud security has historically benefited when governments and regulators tighten expectations on digital risk management, as seen after prior waves of headline breaches. Learning from your earlier PANW trade, this allocation is sized below your highest‑conviction tech picks to respect valuation risk, but it still gives you exposure to a clear, policy‑reinforced cyber theme that is likely to stay in focus over the coming couple of weeks.
NUVL	Nuvalent	Healthcare / Biotechnology	17.4%	-0.18%	+0.06% 5 days	Guardian and CNBC coverage report that GSK is buying Nuvalent for $10.6bn, or $124 per share in cash, with two late‑stage lung‑cancer drugs under FDA review and launches expected later this year, and Nuvalent stock trading a couple of dollars below the offer price after a ~38% pre‑market jump.[guardian,cnbc] For a 1–2 week trade with a 6% stop, a cash M&A deal with near‑term regulatory milestones offers a relatively bounded risk/reward: the stock tends to trade in a tight band below the offer while arb funds accumulate, and short‑term volatility is driven more by deal‑spread dynamics than market beta, aligning with your preference to avoid chasing overextended momentum names while still capturing a news‑driven edge.
LNG	Cheniere Energy Inc	Energy	18.3%	+0.47%	-0.28% 2 days	CNBC and other outlets note that U.S. LNG has become India’s primary gas source after Iran‑related disruptions cut off traditional Gulf supplies, and Cheniere—via its Sabine Pass and Corpus Christi export terminals—is the flagship U.S. LNG exporter positioned to serve this rerouted trade. Elevated LNG volumes and firm contract pricing into Asia underpin cash flow in the near term, and any further contract announcements or commentary about U.S. cargoes replacing Gulf supplies can act as incremental catalysts over the next couple of weeks. The stock is volatile but very liquid; paired with a predefined 6% stop, it offers a targeted way to express the current Middle East–driven gas trade without relying on speculative political statements.

Recent Events

[Sat 17:55:56] Fund value per share $0.953. Version:20260605_0913
[Sat 16:53:35] Fund value per share $0.953. Version:20260605_0913
[Sat 15:51:16] Fund value per share $0.953. Version:20260605_0913
[Sat 14:48:51] Fund value per share $0.953. Version:20260605_0913
[Sat 13:46:25] Fund value per share $0.953. Version:20260605_0913
[Sat 12:44:01] Fund value per share $0.953. Version:20260605_0913
[Sat 11:41:41] Fund value per share $0.953. Version:20260605_0913
[Sat 10:39:20] Fund value per share $0.953. Version:20260605_0913
[Sat 09:36:58] Fund value per share $0.953. Version:20260605_0913
[Sat 08:34:32] Fund value per share $0.953. Version:20260605_0913
[Sat 07:32:08] Fund value per share $0.953. Version:20260605_0913
[Sat 06:29:47] Fund value per share $0.953. Version:20260605_0913
[Sat 05:27:28] Fund value per share $0.953. Version:20260605_0913
[Sat 04:25:10] Fund value per share $0.953. Version:20260605_0913
[Sat 03:22:50] Fund value per share $0.953. Version:20260605_0913
[Sat 02:20:28] Fund value per share $0.953. Version:20260605_0913
[Sat 01:18:10] Fund value per share $0.953. Version:20260605_0913
[Sat 00:15:48] Fund value per share $0.953. Version:20260605_0913
[Fri 23:13:25] Fund value per share $0.953. Version:20260605_0913
[Fri 22:52:50] Timed maintenance: weekly tick (no tasks configured yet).
[Fri 22:11:03] Fund value per share $0.953. Version:20260605_0913
[Fri 21:08:40] Fund value per share $0.953. Version:20260605_0913
[Fri 20:06:20] Fund value per share $0.953. Version:20260605_0913
[Fri 19:03:59] Fund value per share $0.953. Version:20260605_0913
[Fri 18:01:37] Fund value per share $0.953. Version:20260605_0913
[Fri 17:09:48] Successfully placed trailing stop order for LNG with 6.0% trailing amount
[Fri 16:59:14] Fund value per share $0.953. Version:20260605_0913
[Fri 15:56:56] Fund value per share $0.953. Version:20260605_0913
[Fri 14:54:36] Fund value per share $0.953. Version:20260605_0913
[Fri 13:52:14] Fund value per share $0.953. Version:20260605_0913
[Fri 12:53:25] Fund value per share $0.952. Version:20260605_0913
[Fri 12:31:43] BOUGHT: LNG. 18.4% of portfolio
[Fri 12:31:35] Perplexity final stock selection cost: $0.01 (4,782 total, 4,522 input, 260 output, model: sonar-reasoning-pro)
[Fri 12:31:11] Perplexity batch stock recommendation cost: $0.22 (105,136 total, 104,088 input, 1,048 output, model: sonar-reasoning-pro)
[Fri 12:30:06] Guardian headline trimming - Top 5 filtered sections: us-news: 62, world: 62, uk-news: 33, politics: 27, australia-news: 23
[Fri 12:30:06] Headline trimming: 710 → 48 headlines (BBC 166→0, Guardian 441→18, NPR 47→0, CNBC 56→30)
[Fri 12:30:06] Perplexity headline filtering cost: $0.07 (23,390 total, 23,136 input, 254 output, model: sonar)
[Fri 12:30:03] Filtering 710 headlines for market influence over next 14 days
[Fri 12:29:53] Limiting this buy round to 1 position(s) due to available cash ($1724.15) versus target position size ($919.93).
[Fri 12:29:53] 18.7% of funds available - looking for opportunities. 8 current positions. Asking Perplexity to recommend up to 1 new position(s)
[Fri 11:54:47] Fund value per share $0.954. Version:20260605_0913
[Fri 11:33:19] Order failed - no response from Robinhood for AMZN
[Fri 11:15:48] Order failed - no response from Robinhood for EQIX
[Fri 11:10:19] Order failed - no response from Robinhood for SLB
[Fri 10:55:17] Fund value per share $0.955. Version:20260605_0913
[Fri 10:43:11] Order failed - no response from Robinhood for SLB
[Fri 09:56:00] Fund value per share $0.953. Version:20260605_0913
[Fri 08:56:37] Fund value per share $0.954. Version:20260605_0913
[Fri 08:56:24] Fund value per share $0.179. Version:20260605_0913
[Fri 08:49:49] Order failed - no response from Robinhood for NUVL